Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors.
about
Anti-HIV-1 nanotherapeutics: promises and challenges for the futureSpecific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavirProgress in antiretroviral drug delivery using nanotechnologyPhotodynamic therapy and two-photon bio-imaging applications of hydrophobic chromophores through amphiphilic polymer delivery.Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.Substrate-dependent breast cancer resistance protein (Bcrp1/Abcg2)-mediated interactions: consideration of multiple binding sites in in vitro assay design.Investigation of the micellar effect of pluronic P85 on P-glycoprotein inhibition: cell accumulation and equilibrium dialysis studies.The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.NanoART, neuroAIDS and CNS drug delivery.How much do antiretroviral drugs penetrate into the central nervous system?Advances in brain targeting and drug delivery of anti-HIV therapeutic agents.Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.Inhibition of P-glycoprotein pumps by PEO-PPO amphiphiles: branched versus linear derivatives.P-glycoproteins play a role in ivermectin resistance in cyathostomins.Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV.Development of peptide inhibitors of HIV transmission.
P2860
Q26828464-DBE4089F-C01B-40D0-9852-121A31E668C2Q28534049-1B5C3C57-1876-40E2-90B6-7C6FFD76E599Q30395011-C1CEEB36-2E08-48A1-88C4-45216DE1A174Q33875267-21E97484-FEF2-429B-891C-D81CB6DC7175Q37113947-ED3BE5F3-AF70-4215-9BD4-FA9E34CA3808Q37172880-0D099580-C387-4888-BF1B-7F88D7511DB8Q37187988-82E214E3-FEC8-431D-AACF-24E990382BEFQ37371578-6B560C34-F06A-4487-AEF5-28D96F24B3E7Q37379470-8F6120B9-0CCD-4A19-A406-DEDCF8D9ABADQ37538776-18ABA726-D5D7-49FE-A291-77CEDDA79311Q38003612-C400E870-33CB-4C7B-BB70-7ED192A14DBAQ38091126-ABCC602B-E50D-42BD-B2A1-0C682A6154DFQ40060003-E8B4F58B-1B31-40F1-B5D2-CFCD10AB6D08Q42786611-DF900D56-DCEC-4AB9-AE51-C451106D957DQ46161236-EB704C0E-4986-463D-B275-C89F60601FFCQ48284053-75BF8385-A968-4FFA-8C52-88C588D2DCAAQ55317261-5790F212-8980-4802-807E-5280639CA928
P2860
Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interactions of pluronic block ...... ith HIV-1 protease inhibitors.
@en
Interactions of pluronic block ...... ith HIV-1 protease inhibitors.
@nl
type
label
Interactions of pluronic block ...... ith HIV-1 protease inhibitors.
@en
Interactions of pluronic block ...... ith HIV-1 protease inhibitors.
@nl
prefLabel
Interactions of pluronic block ...... ith HIV-1 protease inhibitors.
@en
Interactions of pluronic block ...... ith HIV-1 protease inhibitors.
@nl
P2093
P2860
P356
P1476
Interactions of pluronic block ...... ith HIV-1 protease inhibitors.
@en
P2093
Naveed Shaik
William F Elmquist
P2860
P304
P356
10.1002/JPS.21372
P407
P577
2008-12-01T00:00:00Z